A top PhRMA executive, who's been a major force on Capitol Hill on 340B issues for over two decades, announced last week that she will leave the brand A top PhRMA executive, who's been a major force on Capitol Hill on 340B issues for over two decades, announced last week that she will leave the brand name drug industry trade group in September to join AbbVie’s leadership team.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.